1.68
-0.035(-2.05%)
Currency In USD
| Previous Close | 1.71 |
| Open | 1.72 |
| Day High | 1.75 |
| Day Low | 1.67 |
| 52-Week High | 6.01 |
| 52-Week Low | 1.52 |
| Volume | 700,843 |
| Average Volume | 929,363 |
| Market Cap | 142.09M |
| PE | -2.29 |
| EPS | -0.73 |
| Moving Average 50 Days | 2.13 |
| Moving Average 200 Days | 2.47 |
| Change | -0.04 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $416.67 as of December 14, 2025 at a share price of $1.675. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $88.91 as of December 14, 2025 at a share price of $1.675.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis Announces Signing of Lease for GMP Manufacturing Facility
GlobeNewswire Inc.
Nov 10, 2025 2:00 PM GMT
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 3
Codexis to Report Third Quarter 2025 Financial Results on November 6
GlobeNewswire Inc.
Oct 23, 2025 11:05 AM GMT
REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial
Codexis to Participate in Cantor Global Healthcare Conference
GlobeNewswire Inc.
Aug 28, 2025 1:00 PM GMT
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor